Scope of the Study
Microorganisms can harmful to humans as they can spoil food, introduce toxins, cause disease and lead to a host of other problems. Thus it is important to identify these contaminants and treat them before they do irreversible damage. Microbiology testing is an examination of the microscopic organisms in the given sample. Rapid microbiology testing helps to expose microbial contamination in a matter of hours as opposed to the days required for traditional methods. It detects the presence of a single organism within hours.
The market study is being classified, by Application (Clinical Disease Diagnosis, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Cosmetics & Personal Care Products Testing, Environmental Testing, Research Applications and Other Applications (chemicals, paints, and biofuels)) and major geographies with country level break-up.
Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), bioMérieux (France), BD (United States), Danaher (United States), Thermo Fisher (United States), Bio-Rad (United States), Accelerate (United States) and Alifax (Italy) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Creative Diagnostics (United States), Merck Group(Germany), Synbiosis (United Kingdom), Bioanalyse (Turkey) and Zhuhai DL Biotech (China).
The major players are investing in the rapid microbiology testing market. They are focusing on research and development activities. It helps to gain competitive advantage in the market. They are also focusing on acquisitions and partnerships in the new markets.
AdvanceMarketAnalytics has segmented the market of Global Rapid Microbiology Testing market by Type, Application and Region.
On the basis of geography, the market of Rapid Microbiology Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Acceptance of Rapid Microbiology Testing
- Increased Incidences of Infectious Diseases
- Rise in the Food Safety Concerns
- Increased Research and Development Investments
- Unfavorable Reimbursement Policies
- Increasing Opportunities from Developing Regions
- Growth in the Healthcare Industry Worldwide
- Rise in the Number of Diagnostic Laboratories in Developing Regions
- High Cost of Rapid Microbiology Testing Instruments
Market Leaders and their expansionary development strategies
Recently, Bruker has announced the closing of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Germany. MERLIN has in-depth expertise in products, services and consulting in the fields of antibiotic resistance testing (ART) and antibiotic susceptibility testing (AST).
Key Target AudienceRapid Microbiology Testing Providers, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase